How to Treat Heliobacter pylori: First-Line, Second-Line, and Future Therapies
- 1 December 2000
- journal article
- review article
- Published by Elsevier BV in Gastroenterology Clinics of North America
- Vol. 29 (4), 759-773
- https://doi.org/10.1016/s0889-8553(05)70145-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication ratesAlimentary Pharmacology & Therapeutics, 1999
- Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysisAlimentary Pharmacology & Therapeutics, 1999
- Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1999
- Furazolidone‐containing short‐term triple therapies are effective in the treatment of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1999
- New therapy for H. pylori: Omeprazole-metronidazole-tetracycline and the effect of tetracycline resistanceGastroenterology, 1998
- Comparison of two one-week triple therapies with a low dose of lansoprazole and two low-dose antibiotics in Helicobacter pylori eradication: A French studyGastroenterology, 1998
- Ranitidine bismuth citrate with metronidazole and tetracycline is an effective and inexpensive treatment for the eradication of H. pyloriGastroenterology, 1998
- Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.Gut, 1995
- Clarithromycin for the Eradication of Helicobacter PyloriJournal of Clinical Gastroenterology, 1993
- V. Helicobacter pylori therapy: Effect on peptic ulcer diseaseJournal of Gastroenterology and Hepatology, 1991